Product image of Nystatyna Teva (Nystatin) supplied by GNH India

Nystatyna Teva

Active Ingredient:
Nystatin
Origin:
EU

Nystatyna Teva (Nystatin)

Nystatin, the active ingredient in Nystatyna Teva, is a polyene antifungal presented as an oral dosage form for oral use. It treats Candida infections of the mouth and esophagus in patients with oral or esophageal candidiasis.
GNH India supplies Nystatyna Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teva Pharmaceuticals Polska Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nystatin is a polyene antifungal that acts on Candida species affecting the oral and upper gastrointestinal tract.

  • Oral candidiasis (thrush): reduces fungal load and relieves symptoms in patients with mouth Candida infection.
  • Esophageal candidiasis: clears Candida from the esophagus, improving swallowing and reducing pain.
  • Denture‑related stomatitis: eliminates Candida overgrowth on denture surfaces, helping resolve inflammation.

How It Works

  • Nystatin binds to ergosterol, a key sterol component of fungal cell membranes. This interaction creates pores that increase membrane permeability, leading to leakage of intracellular contents and ultimately causing fungal cell death without significant absorption into human tissues.

Side Effects

Nystatin may cause adverse reactions, most of which are mild and limited to the gastrointestinal tract or skin.

Common Side Effects

  • Nausea: mild discomfort in the stomach after oral administration.
  • Vomiting: occasional expulsion of stomach contents.
  • Diarrhea: loose stools occurring during treatment.
  • Abdominal pain: cramping or discomfort in the abdomen.
  • Altered taste: temporary change in taste perception.
  • Mild rash: skin redness or itching at the site of contact.

Serious or Rare Side Effects

  • Severe allergic reaction: anaphylaxis with difficulty breathing, swelling, or hives.
  • Hepatotoxicity: rare liver enzyme elevation requiring monitoring.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Persistent vomiting: leading to dehydration or electrolyte imbalance.
  • Rare neutropenia: significant drop in white blood cells.
  • Unexplained fever: may indicate systemic infection.

Precautions & Warnings

Before using Nystatyna Teva, consider the following safety measures.

  • Pregnancy: consult a healthcare professional; safety data are limited.
  • Breastfeeding: discuss potential risks with a physician.
  • Renal impairment: use with caution as excretion may be reduced.
  • Known hypersensitivity: avoid if allergic to nystatin or other polyenes.
  • Concomitant medications: review all drugs to identify potential interactions.
  • Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Nystatyna Teva has a low potential for drug‑drug interactions, but certain combinations warrant attention.

Major Interactions (Avoid)

  • None reported: no clinically significant major interactions have been identified.

Moderate Interactions (Monitor Closely)

  • Oral antibiotics: may alter gut flora and affect Candida balance.
  • Other antifungal agents: monitor for additive gastrointestinal irritation.
  • Antacids: could affect dissolution and absorption of the oral formulation.
  • Probiotics: may reduce antifungal efficacy, requiring clinical observation.
  • Immunosuppressants: increased risk of opportunistic infections; monitor patient closely.

Frequently Asked Questions

Nystatyna Teva contains nystatin, which is indicated for the treatment of oral candidiasis (thrush) and esophageal candidiasis caused by Candida species. It may also be used to manage denture‑related stomatitis where Candida overgrowth contributes to inflammation.

Nystatin binds to ergosterol in the fungal cell membrane, forming pores that increase membrane permeability. This disrupts the integrity of the cell, causing leakage of essential intracellular components and leading to fungal cell death, while remaining poorly absorbed systemically.

The dosage of Nystatyna Teva is determined by the prescribing clinician based on the patient’s age, weight, severity of infection, and specific formulation. The prescriber will provide the appropriate dosing schedule and duration of therapy.

Safety data for nystatin in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Nystatyna Teva.

To order Nystatyna Teva, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nystatin is a polyene antifungal that acts locally in the gastrointestinal tract and has minimal systemic absorption, making it suitable for mucosal Candida infections. Unlike azole antifungals, it does not inhibit cytochrome P450 enzymes, resulting in fewer drug‑drug interactions, but it is limited to topical or oral use for superficial infections.

Nystatyna Teva should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Keeping the product in a cool, dry place helps maintain its stability and potency throughout its shelf life.

Nystatyna Teva is taken orally, typically as a suspension or tablet, as directed by the prescribing clinician. The medication should be swallowed or, if a suspension, swished around the mouth and then swallowed to ensure contact with the affected mucosal surfaces.

Although rare, serious adverse reactions can include severe allergic responses such as anaphylaxis, significant liver enzyme elevations indicating hepatotoxicity, and rare severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, rash, or persistent vomiting.

Individuals with a known hypersensitivity to nystatin or other polyene antifungals should avoid using Nystatyna Teva. Additionally, patients with severe renal impairment should use the product only under close medical supervision, and pregnant or breastfeeding women should consult their healthcare provider before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.